Breaking News

Crispr Therapeutics AG (CRSP)

Symbol	Exchange	Currency
CRSP	NASDAQ	USD	Real-time
CRSPN	Mexico	MXN	Delayed
CRSPN	BIVA	MXN	Delayed

Add to/Remove from a Portfolio Add to Watchlist

57.65 -1.37 -2.32%

30/07 - Closed. Currency in USD

After Hours

57.60

-0.08

-0.14%

00:44:38 - Real-time Data

Type: Equity

Market: United States

Volume: 2,950,013
Bid/Ask: 0.00 / 0.00
Day's Range: 56.49 - 61.38

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Crispr Therapeutics AG Company Profile

Get an in-depth profile of Crispr Therapeutics AG, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

407

Equity Type

ORD

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as develops investigational CAR T programs, including an autologous, gene-edited CAR T program targeting glypican-3 (GPC3) for the potential treatment of solid tumors. The company’s lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease (SCD), and hemoglobinopathies in which a patient’s hematopoietic stem and progenitor cells are edited to produce high levels of fetal hemoglobin in red blood cells. It also develops CAR T cell therapies, including CTX112 targeting cluster of differentiation 19 (CD19) and CTX131 targeting CD70 for oncology and autoimmune indications; CTX310 and CTX320, in vivo gene editing to address the cardiovascular disease by disrupting the validated targets angiopoietin-like protein 3 and lipoprotein; and CTX211, an allogeneic, gene-edited, hypoimmune stem cell-derived product candidate for the treatment of T1D. It has strategic partnerships with Vertex Pharmaceuticals Incorporated, Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.

Contact Information

Address Baarerstrasse 14
Zug, 6300
Switzerland

Phone 41 41 561 32 77

Fax -

Web www.crisprtx.com

Top Executives

Name	Age	Since	Title
Samarth Kulkarni	44	2015	CEO & Chairman
Matthew Porteus	59	-	Scientific Founder & Advisory Board Member
Daniel G. Anderson	-	-	Scientific Founder & Advisory Board Member
Craig C. Mello	-	-	Scientific Founder & Advisory Board Member
Emmanuelle Marie Charpentier	-	-	Co-Founder & Scientific Advisory Board Member
Ali Behbahani	49	2015	Independent Director
John Thomas Greene	59	2019	Independent Director
Simeon John George	48	2015	Independent Director
Maria Fardis	57	2022	Independent Director
H. Edward Fleming	62	2021	Independent Director
Katherine A. High	73	2019	Independent Director
Stephen J. Elledge	-	-	Member of Scientific Advisory Board
Sandesh Mahatme	60	2024	Independent Director
Christian Rommel	58	2024	Independent Director
Briggs Duncan W. Morrison	65	2025	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

CRSP Comments

Write your thoughts about Crispr Therapeutics AG

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,110.26	+51.12	+1.01%
NSE All Share	139,278.67	+1365.80	+0.99%
US 30	44,575.3	+114.0	+0.26%
US 500	6,413.2	+50.3	+0.79%
FTSE 100	9,136.94	+0.62	+0.01%
DAX	24,262.22	+44.85	+0.19%
South Africa Top 40	91,597.63	+76.89	+0.08%

Brent Oil	72.75	+1.07	+1.49%
Crude Oil WTI	70.32	+0.32	+0.46%
Gold	3,332.56	-20.24	-0.60%
Silver	37.185	-0.554	-1.47%
Copper	4.6427	+0.0127	+0.27%
London Cocoa	5,472.00	+16.00	+0.29%
London Wheat	176.95	+1.00	+0.57%

Nigeria 10Y	16.017	+0.062	+0.39%
Nigeria 2Y	16.475	+0.001	+0.01%
U.K. 10Y	4.6020	-0.0350	-0.75%
Germany 10Y	2.7050	+0.0150	+0.56%
U.S. 10Y	4.371	-0.006	-0.14%
U.S. 5Y	3.967	+0.002	+0.05%
U.S. 2Y	3.949	+0.012	+0.30%

Fidelitybk	21.000	+0.500	+2.44%
Zenith Bank	75.00	+2.00	+2.74%
UBA	48.00	+0.20	+0.42%
First HoldCo	34.90	-0.25	-0.71%
Guaranty Trust Holding	101.95	+3.95	+4.03%
Sterling Bank	6.700	0.000	0.00%
Dangote Cement	509.60	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
CRSP	57.65	-1.37	-2.32%
02M	31.77	+0.57	+1.83%
ISP	5.413	+0.193	+3.70%
NCCL	222.55	-0.50	-0.22%
More Government +.	138.120	0.000	0.00%
MiraeAsset TIGER .	52,740	+60	+0.11%
RPRX	37.13	-0.14	-0.38%
1ASSA	29.05	0.00	0.00%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	21.000	+2.44%	90.40M
Guaranty Trust Holding	101.95	+4.03%	30.26M
Nigerian Breweries	77.00	+4.05%	29.34M
Nascon	99.90	+8.59%	16.82M
Lafarge Africa	151.00	+7.63%	14.59M
MTN Nigeria	471.10	+4.32%	6.99M
Dangote Cement	509.60	0.00%	3.59M

Name	Last	Chg. %	Vol.
Royalex	1.54	+10.00%	25.12M
Multverse	9.90	+10.00%	843.76K
Npfmcrfbk	3.420	+9.97%	11.86M
Dangote Sugar	71.15	+9.97%	7.69M
Berger Paints	37.50	+9.97%	2.92M
UAC Of Nigeria	73.00	+9.94%	2.99M
PZ Cussons Nigeria	43.35	+9.89%	6.27M

Name	Last	Chg. %	Vol.
FTN Cocoa Processors PLC	6.30	-10.00%	13.97M
Abbey Mortgage Bank	6.48	-10.00%	754.65K
Livingtrust Mortgage Bank	6.59	-9.97%	103.95K
Sunu Assurances	4.14	-9.61%	11.72M
Consolidated Hallmark	3.20	-7.78%	10.38M
Honeywell Flour Mills Plc	25.050	-7.22%	13.78M
Tantalizers	2.51	-7.04%	4.98M